Clinical Trial Update: Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC) [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating the efficacy of tacrolimus (FK-506) and cyclosporine for vernal keratoconjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vernal Keratoconjunctivitis

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Siriraj Hospital | Conditions: Keratoconjunctivitis, Vernal | Phase 2, Phase 3 | Status: COMPLETED